Literature DB >> 16266774

Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus.

A V Atrasheuskaya1, A A Neverov, S Rubin, G M Ignatyev.   

Abstract

Here we describe symptomatic transmission of the Leningrad-3 mumps vaccine virus from healthy vaccinees to previously vaccinated contacts. Throat swab and serum samples were taken from six symptomatic mumps cases and from 13 family contacts. Assessment of serum IgG and IgM anti-mumps virus antibodies and IgG avidity testing was performed using commercial test kits. Sera neutralizing antibodies were measured by plaque reduction neutralization assay using the L-3 vaccine mumps virus as the target. All six of the symptomatic mumps cases and three contact subjects tested positive for mumps by RT-PCR. The genomic sequences tested (F, SH and HN genes) of all nine of these samples were identical to the L-3 mumps vaccine strain. All 13 contacts were asymptomatic; however clear serological evidence of mumps infection was found in some of them. The likely epidemiological source of the transmitted L-3 mumps virus was children who were recently vaccinated at the schools attended by the six symptomatic mumps patients described here. The L-3 mumps vaccine virus can be shed and transmitted horizontally, even to subjects previously vaccinated with the same virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16266774     DOI: 10.1016/j.vaccine.2005.10.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Horizontal transmission of live vaccines.

Authors:  Prasad S Kulkarni; Suresh S Jadhav; Rajeev M Dhere
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

2.  Unusual patterns of IgG avidity in some young children following two doses of the adjuvanted pandemic H1N1 (2009) influenza virus vaccine.

Authors:  Karen K Yam; Jyotsana Gupta; Angela Brewer; David W Scheifele; Scott Halperin; Brian J Ward
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

Review 3.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

Review 4.  Current view on novel vaccine technologies to combat human infectious diseases.

Authors:  Zrinka Matić; Maja Šantak
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-10       Impact factor: 4.813

5.  Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection.

Authors:  Sara Mercader; Marcia McGrew; Sun B Sowers; Nobia J Williams; William J Bellini; Carole J Hickman
Journal:  mSphere       Date:  2018-09-12       Impact factor: 4.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.